Moleculin Biotech Inc (NASDAQ: MBRX) kicked off on Friday, up 11.87% from the previous trading day, before settling in for the closing price of $0.44. Over the past 52 weeks, MBRX has traded in a range of $0.25-$3.65.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 26.36%. While this was happening, its average annual earnings per share was recorded 80.33%. With a float of $45.11 million, this company’s outstanding shares have now reached $49.50 million.
Moleculin Biotech Inc (MBRX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Moleculin Biotech Inc is 8.87%, while institutional ownership is 0.87%. The most recent insider transaction that took place on Jun 23 ’25, was worth 100,000. In this transaction Chief Financial Officer of this company bought 270,270 shares at a rate of $0.37, taking the stock ownership to the 287,587 shares. Before that another transaction happened on Jun 23 ’25, when Company’s CEO and President bought 675,675 for $0.37, making the entire transaction worth $250,000. This insider now owns 743,607 shares in total.
Moleculin Biotech Inc (MBRX) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -2.85 earnings per share (EPS), lower than consensus estimate (set at -2.44) by -0.41. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.64% during the next five years compared to 26.36% growth over the previous five years of trading.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
Take a look at Moleculin Biotech Inc’s (MBRX) current performance indicators. Last quarter, stock had a quick ratio of 1.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.59, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.05 in one year’s time.
Technical Analysis of Moleculin Biotech Inc (MBRX)
The latest stats from [Moleculin Biotech Inc, MBRX] show that its last 5-days average volume of 3.07 million was inferior to 4.44 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 86.62%.
During the past 100 days, Moleculin Biotech Inc’s (MBRX) raw stochastic average was set at 27.05%, which indicates a significant decrease from 87.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0288 in the past 14 days, which was lower than the 0.0655 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5449, while its 200-day Moving Average is $0.9861. Now, the first resistance to watch is $0.5233. This is followed by the second major resistance level at $0.5547. The third major resistance level sits at $0.5985. If the price goes on to break the first support level at $0.4481, it is likely to go to the next support level at $0.4043. Assuming the price breaks the second support level, the third support level stands at $0.3729.
Moleculin Biotech Inc (NASDAQ: MBRX) Key Stats
The company with the Market Capitalisation of 24.35 million has total of 49,499K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -21,760 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,640 K.
